SOPH

Handel nachbörslich: 5.30 0.010 +0.19%

Sophia Genetics Sa (SOPH)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1111)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SOPH's Discussions on Twitter

Compare SOPH vs VEEV, BTSG, TEM, HQY, DOCS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SOPH Sophia Genetics Sa	5.29	381.28M	77.27M	-79.00M	-48.46M	-1.1694
VEEV Veeva Systems Inc	170.22	28.03B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	53.54	10.16B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	55.81	9.87B	1.27B	-245.03M	-245.36M	-1.4071
HQY Healthequity Inc	82.18	6.96B	1.31B	215.20M	408.32M	2.4627
DOCS Doximity Inc	24.89	4.61B	637.78M	239.40M	307.21M	1.1909

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-18	Eingeleitet	Craig Hallum	Buy
2024-08-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Eingeleitet	Guggenheim	Buy
2023-11-29	Eingeleitet	RBC Capital Mkts	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-01-03	Eingeleitet	BTIG Research	Buy
2022-11-23	Eingeleitet	Credit Suisse	Neutral
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-17	Eingeleitet	Cowen	Outperform
2021-08-17	Eingeleitet	Credit Suisse	Outperform
2021-08-17	Eingeleitet	JP Morgan	Overweight
2021-08-17	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Compare SOPH vs VEEV, BTSG, TEM, HQY, DOCS

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,100.00 in Stock - MarketBeat

SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under 10b5-1 plan - Stock Titan

Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Drops By 31.0% - MarketBeat

SOPHiA GENETICS (SOPH) Projected to Post Earnings on Tuesday - MarketBeat

SOPH Price Today: SOPHiA GENETICS SA Stock Price, Quote & Chart | MEXC - MEXC Exchange

Tangible book value per share of SOPHiA GENETICS SA – LS:A3CVT8 - TradingView

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results (PR Newswire) - Aktiellt

SOPHiA (SOPH) Industry Outlook | SOPHiA GENETICS SA misses EPS by 3.2% on $77.3M revenueProfit - Cổng thông tin điện tử tỉnh Lào Cai

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells 4,486 Shares of Stock - MarketBeat

SOPHiA GENETICS (SOPH) HR chief sells 380 shares to cover RSU taxes - Stock Titan

SOPHiA GENETICS (SOPH) CSO sells 608 shares under 10b5-1 plan - Stock Titan

SOPHiA GENETICS (SOPH) legal chief sells 684 shares for tax withholding - Stock Titan

CEO’s tax-driven share sale at SOPHiA GENETICS (SOPH) detailed - Stock Titan

SOPHiA GENETICS (SOPH) CMO tax-related sale of 608 shares under 10b5-1 plan - Stock Titan

Tax-driven SOPHiA GENETICS (SOPH) insider sale under Rule 10b5-1 plan - Stock Titan

Tax-related sell-to-cover by SOPHiA GENETICS (SOPH) Chief Sales Officer - Stock Titan

SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026 - Finviz

Multiple 10b5-1 sales by SOPH insider (NASDAQ: SOPH) reported - Stock Titan

[144] SOPHiA GENETICS SA SEC Filing - Stock Titan

SOPH (NASDAQ: SOPH) lists 10b5-1 sales including 3,824 shares on 04/08/2026 - Stock Titan

Multiple 10b5‑1 insider sales reported at SOPH (NASDAQ: SOPH) - Stock Titan

760-share Rule 144 notice; SOPH (NASDAQ: SOPH) lists 10b5-1 trades Feb–Apr 2026 - Stock Titan

SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 - Sahm

Insider Sell: Zhenyu Xu Sells Shares of Sophia Genetics SA - GuruFocus

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) President Sells 2,800 Shares of Stock - MarketBeat

Jurgi Camblong Sells 43,129 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $87,365.00 in Stock - MarketBeat

SOPHiA GENETICS (SOPH) CSO executes 600-share Rule 10b5-1 sale - Stock Titan

SOPHiA GENETICS (SOPH) CEO’s 60,602-share sale funds RSU tax withholding - Stock Titan

[Form 4] SOPHiA GENETICS SA Insider Trading Activity - Stock Titan

SOPHiA GENETICS (SOPH) president sells 2,800 shares under Rule 10b5-1 tax plan - Stock Titan

SOPH SEC FilingsSophia Genetics Sa 10-K, 10-Q, 8-K Forms - Stock Titan

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 – Company AnnouncementFT.com - Financial Times

SOPH Maintained by BTIG -- Price Target Raised to $8.00 - GuruFocus

BTIG raises Sophia Genetics stock price target on data strategy By Investing.com - Investing.com Australia

SOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 3,706 Shares - MarketBeat

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) President Sells 3,687 Shares of Stock - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) CEO Jurgi Camblong Sells 4,399 Shares - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $21,010.64 in Stock - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) President Ross Muken Sells 4,442 Shares - MarketBeat

Tax-driven 2,400-share sale by SOPHiA GENETICS (SOPH) legal chief - Stock Titan

SOPHiA GENETICS (SOPH) CSO pre‑planned sale covers RSU tax bill - Stock Titan

Tax-driven stock sales by SOPHiA GENETICS (SOPH) CEO under 10b5-1 - Stock Titan

SOPHiA GENETICS (SOPH) president sells 8,129 shares under 10b5-1 tax plan - Stock Titan

SOPHiA GENETICS (SOPH) CMO pre-planned tax-related sale of 8,125 shares - Stock Titan

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $13,552.00 in Stock - MarketBeat

Philippe Menu Sells 2,800 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $13,552.00 in Stock - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) President Sells $13,484.24 in Stock - MarketBeat

Manuela Valente Sells 3,824 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SOPH